杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/01/10 | 1,747 | 1,768 | 1,742 | 1,768 | +18 | +1% | 166,500 |
2013/01/09 | 1,734 | 1,758 | 1,721 | 1,750 | +16 | +0.9% | 194,800 |
2013/01/08 | 1,729 | 1,748 | 1,724 | 1,734 | +13 | +0.8% | 257,700 |
2013/01/07 | 1,721 | 1,729 | 1,710 | 1,721 | -1 | -0.1% | 140,200 |
2013/01/04 | 1,714 | 1,724 | 1,693 | 1,722 | +46 | +2.7% | 252,600 |
2012/12/28 | 1,691 | 1,693 | 1,675 | 1,676 | +2 | +0.1% | 228,400 |
2012/12/27 | 1,687 | 1,692 | 1,674 | 1,674 | -15 | -0.9% | 154,400 |
2012/12/26 | 1,695 | 1,702 | 1,674 | 1,689 | +9 | +0.5% | 112,800 |
2012/12/25 | 1,714 | 1,714 | 1,676 | 1,680 | +2 | +0.1% | 170,200 |
2012/12/21 | 1,690 | 1,690 | 1,672 | 1,678 | -10 | -0.6% | 279,500 |
2012/12/20 | 1,663 | 1,728 | 1,663 | 1,688 | +35 | +2.1% | 371,300 |
2012/12/19 | 1,652 | 1,659 | 1,643 | 1,653 | +3 | +0.2% | 288,400 |
2012/12/18 | 1,670 | 1,686 | 1,650 | 1,650 | -23 | -1.4% | 342,500 |
2012/12/17 | 1,674 | 1,692 | 1,664 | 1,673 | +10 | +0.6% | 279,800 |
2012/12/14 | 1,701 | 1,714 | 1,663 | 1,663 | -37 | -2.2% | 408,600 |
2012/12/13 | 1,739 | 1,739 | 1,696 | 1,700 | -34 | -2% | 248,100 |
2012/12/12 | 1,737 | 1,742 | 1,712 | 1,734 | -2 | -0.1% | 158,000 |
2012/12/11 | 1,757 | 1,763 | 1,731 | 1,736 | -18 | -1% | 148,900 |
2012/12/10 | 1,780 | 1,782 | 1,749 | 1,754 | +14 | +0.8% | 154,200 |
2012/12/07 | 1,743 | 1,749 | 1,732 | 1,740 | -7 | -0.4% | 132,000 |
2012/12/06 | 1,751 | 1,770 | 1,741 | 1,747 | -14 | -0.8% | 204,400 |
2012/12/05 | 1,759 | 1,773 | 1,752 | 1,761 | -1 | -0.1% | 151,300 |
2012/12/04 | 1,732 | 1,769 | 1,732 | 1,762 | +23 | +1.3% | 178,200 |
2012/12/03 | 1,754 | 1,756 | 1,729 | 1,739 | -15 | -0.9% | 224,500 |
2012/11/30 | 1,771 | 1,776 | 1,752 | 1,754 | -11 | -0.6% | 261,600 |
2012/11/29 | 1,772 | 1,775 | 1,753 | 1,765 | -16 | -0.9% | 250,500 |
2012/11/28 | 1,776 | 1,813 | 1,772 | 1,781 | +30 | +1.7% | 393,800 |
2012/11/27 | 1,725 | 1,778 | 1,725 | 1,751 | +28 | +1.6% | 652,800 |
2012/11/26 | 1,750 | 1,752 | 1,721 | 1,723 | -22 | -1.3% | 491,400 |
2012/11/22 | 1,798 | 1,803 | 1,741 | 1,745 | -52 | -2.9% | 487,100 |
2012/11/21 | 1,800 | 1,819 | 1,789 | 1,797 | -10 | -0.6% | 267,100 |
2012/11/20 | 1,799 | 1,819 | 1,798 | 1,807 | +8 | +0.4% | 196,400 |
2012/11/19 | 1,800 | 1,820 | 1,792 | 1,799 | -27 | -1.5% | 416,400 |
2012/11/16 | 1,818 | 1,837 | 1,805 | 1,826 | -1 | -0.1% | 353,000 |
2012/11/15 | 1,821 | 1,830 | 1,800 | 1,827 | +6 | +0.3% | 419,400 |
2012/11/14 | 1,784 | 1,827 | 1,780 | 1,821 | +56 | +3.2% | 536,100 |
2012/11/13 | 1,752 | 1,777 | 1,739 | 1,765 | ±0 | ±0% | 454,300 |
2012/11/12 | 1,780 | 1,781 | 1,750 | 1,765 | -24 | -1.3% | 373,500 |
2012/11/09 | 1,759 | 1,824 | 1,755 | 1,789 | +39 | +2.2% | 826,500 |
2012/11/08 | 1,680 | 1,757 | 1,677 | 1,750 | +77 | +4.6% | 905,100 |
2012/11/07 | 1,710 | 1,787 | 1,662 | 1,673 | -43 | -2.5% | 757,900 |
2012/11/06 | 1,736 | 1,742 | 1,713 | 1,716 | -23 | -1.3% | 343,800 |
2012/11/05 | 1,747 | 1,754 | 1,733 | 1,739 | -7 | -0.4% | 192,800 |
2012/11/02 | 1,726 | 1,752 | 1,726 | 1,746 | +27 | +1.6% | 572,100 |
2012/11/01 | 1,696 | 1,722 | 1,685 | 1,719 | +31 | +1.8% | 479,700 |
2012/10/31 | 1,704 | 1,704 | 1,683 | 1,688 | -2 | -0.1% | 425,900 |
2012/10/30 | 1,697 | 1,698 | 1,684 | 1,690 | +1 | +0.1% | 595,200 |
2012/10/29 | 1,705 | 1,708 | 1,683 | 1,689 | -9 | -0.5% | 397,300 |
2012/10/26 | 1,704 | 1,718 | 1,694 | 1,698 | -7 | -0.4% | 521,900 |
2012/10/25 | 1,682 | 1,705 | 1,673 | 1,705 | +30 | +1.8% | 867,200 |
3001~
3050
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム